PCOS Forum: research in polycystic ovary syndrome today and tomorrow
R Pasquali, E Stener‐Victorin, BO Yildiz… - Clinical …, 2011 - Wiley Online Library
Objective To summarize promising areas of investigation into polycystic ovary syndrome
(PCOS) and to stimulate further research in this area. Design Summary of a conference held …
(PCOS) and to stimulate further research in this area. Design Summary of a conference held …
The role of polycystic ovary syndrome in reproductive and metabolic health: overview and approaches for treatment
CC Dennett, J Simon - Diabetes Spectrum, 2015 - Am Diabetes Assoc
(SHBG)(13). Reduced SHBG levels lead to an increase in free testosterone levels (14).
Women with PCOS who have chronic anovulation but normal androgen levels tend to not be …
Women with PCOS who have chronic anovulation but normal androgen levels tend to not be …
Molecular mysteries of polycystic ovary syndrome
JF Strauss III, A Dunaif - Molecular Endocrinology, 1999 - academic.oup.com
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of women of
reproductive age, affecting from 5–10% of women in this age group (1, 2). The symptoms of …
reproductive age, affecting from 5–10% of women in this age group (1, 2). The symptoms of …
[HTML][HTML] Polycystic ovary syndrome (PCOS): international collaboration to translate evidence and guide future research
Polycystic ovary syndrome (PCOS) affects 8–13% of reproductive-aged women, impacts
biopsychosocial factors and creates a significant health-related economic burden across the …
biopsychosocial factors and creates a significant health-related economic burden across the …
Polycystic ovary syndrome: the epigenetics behind the disease
MC Eiras, DP Pinheiro, KAM Romcy, RA Ferriani… - Reproductive …, 2022 - Springer
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders,
affecting approximately 5–20% of women of reproductive age. PCOS is a multifactorial …
affecting approximately 5–20% of women of reproductive age. PCOS is a multifactorial …
[HTML][HTML] Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop …
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in females, with
a high prevalence. The etiology of this heterogeneous condition remains obscure, and its …
a high prevalence. The etiology of this heterogeneous condition remains obscure, and its …
Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome
DA Dumesic, SE Oberfield, E Stener-Victorin… - Endocrine …, 2015 - academic.oup.com
Polycystic ovary syndrome (PCOS) is a heterogeneous and complex disorder that has both
adverse reproductive and metabolic implications for affected women. However, there is …
adverse reproductive and metabolic implications for affected women. However, there is …
[HTML][HTML] Polycystic ovary syndrome: An updated overview foregrounding impacts of ethnicities and geographic variations
A Yasmin, S Roychoudhury, A Paul Choudhury… - Life, 2022 - mdpi.com
Polycystic ovary syndrome (PCOS) is one of the most common heterogeneous conditions of
the endocrine reproductive system in women of childbearing age. Hyperandrogenism and …
the endocrine reproductive system in women of childbearing age. Hyperandrogenism and …
Hyperandrogenic origins of polycystic ovary syndrome–implications for pathophysiology and therapy
DH Abbott, DA Dumesic, JE Levine - Expert review of …, 2019 - Taylor & Francis
Introduction: Polycystic ovary syndrome (PCOS) diagnosis comprises combinations of
female hyperandrogenism, menstrual irregularity and polycystic ovaries. While it is a familial …
female hyperandrogenism, menstrual irregularity and polycystic ovaries. While it is a familial …
The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited
RL Rosenfield, DA Ehrmann - Endocrine reviews, 2016 - academic.oup.com
Polycystic ovary syndrome (PCOS) was hypothesized to result from functional ovarian
hyperandrogenism (FOH) due to dysregulation of androgen secretion in 1989–1995 …
hyperandrogenism (FOH) due to dysregulation of androgen secretion in 1989–1995 …